Low Power HOLEP Versus TURP

Low Power HOLEP Versus TURP in Management of BPH

Status

Enrolling by invitation

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07741214

Acronym

HOLEP vs TURP

Enrollment

100

Registered

2026-08-03

Start date

2026-08-01

Completion date

2027-11-01

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BPH With Urinary Obstruction, Prostatic Hyperplasia

Keywords

Low power HOLEP, TURP, HOLEP, BPH

Brief summary

Patients with obstructed flow due to BPH will be enrolled into 2 groups, group will undergo TURP and the other group will undergo Low power HOLEP

Interventions

PROCEDURElow power HOLEP

Patients who will undergo transurethral resection of the prostate

PROCEDURETURP

Patients who will undergo transurethral resection of the prostate

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

50 Years to No maximum

Healthy volunteers

Inclusion criteria

\- mens with LUTS due to obstructed prostate

Exclusion criteria

* stone bladder bladder cancer prostate cancer

Design outcomes

Primary

Measure	Time frame	Description
Change in The International Prostate Symptom Score (IPSS)	6 months	The International Prostate Symptom Score (IPSS) can be utilized to measure the severity of lower urinary tract symptoms. It is a validated, reproducible scoring system to assess disease severity and response to therapy. The IPSS is made up of 7 questions related to voiding symptoms. A score of 0 to 7 indicates mild symptoms, 8 to 19 indicates moderate symptoms and 20 to 35 indicates severe symptoms.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 4, 2026